We are live on ! Find out more
GHRS icon

GH Research

34 hedge funds and large institutions have $348M invested in GH Research in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $309M → $348M (+$39.5M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.85% less ownership

Funds ownership: 62.59%60.74% (-1.8%)

3% less funds holding

Funds holding: 3534 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.59%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
8
Reduced
12
Closed
4
Calls
Puts
Net Calls
Net Calls Change

GHRS Hedge Fund Activity: Q3 2022 in Review

34 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in GH Research (GHRS) for Q3 2022, worth a combined $348M — up 13% from $309M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of GHRS and 3 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 8 added.

The largest buyer was VR Adviser, adding an estimated $1.86M. The largest seller was Boxer Capital, exiting entirely with an estimated $10.1M sold.

  • 34 institutional investors held GH Research (GHRS) as of Q3 2022, down from 35 in Q2 2022.
  • Funds reported $348M of GH Research stock for Q3 2022, up 13% quarter-over-quarter.
  • 3 funds opened new GH Research positions in Q3 2022 and 4 closed out, a net change of -1 holder.
  • The largest GH Research buyer in Q3 2022 was VR Adviser, an estimated $1.86M added.
  • The largest GH Research seller in Q3 2022 was Boxer Capital, an estimated $10.1M sold.

Based on aggregated 13F filings for Q3 2022.